ST
NVO

Spot Trading’s Novo Nordisk NVO Stock Holding History

Spot Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,876
Closed -$427K – 3299
2017
Q2 		$405K Sell
18,876
-11,424
-38% -$231K 0.01% 1756
2017
Q1 		$519K Buy
30,300
+18,258
+152% +$318K 0.02% 1216
2016
Q4 		$216K Buy
+12,042
New +$218K 0.01% 1878
2016
Q2 		– Sell
-68,434
Closed -$1.85M – 3666
2016
Q1 		$1.85M Buy
+68,434
New +$1.83M 0.03% 733
2014
Q1 		– Sell
-720
Closed -$13K – 4415
2013
Q4 		$13K Sell
720
-39,450
-98% -$688K ﹤0.01% 3732
2013
Q3 		$680K Buy
+40,170
New +$676K ﹤0.01% 2202

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Spot Trading's NVO Position: Q3 2017 in Review

Spot Trading sold out of Novo Nordisk (NVO) in Q3 2017, closing a stake of 18,876 shares — an estimated $427K sold.

Spot Trading first reported a position in NVO in Q3 2013 and held it in 6 quarters. The position peaked at $1.85M in Q1 2016. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

  • Spot Trading reported no remaining Novo Nordisk position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 18,876 Novo Nordisk shares in Q3 2017, an estimated $427K.
  • Spot Trading first reported a position in Novo Nordisk in Q3 2013 and held it in 6 quarters.
  • Spot Trading's Novo Nordisk position peaked at $1.85M in Q1 2016.
  • 491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.